176 related articles for article (PubMed ID: 15585078)
1. Proteomic analysis of human breast cancer tissue with laser-capture microdissection and reverse-phase protein microarrays.
Cowherd SM; Espina VA; Petricoin EF; Liotta LA
Clin Breast Cancer; 2004 Dec; 5(5):385-92. PubMed ID: 15585078
[TBL] [Abstract][Full Text] [Related]
2. Use of proteomic analysis to monitor responses to biological therapies.
Espina V; Dettloff KA; Cowherd S; Petricoin EF; Liotta LA
Expert Opin Biol Ther; 2004 Jan; 4(1):83-93. PubMed ID: 14680471
[TBL] [Abstract][Full Text] [Related]
3. Laser capture microdissection and advanced molecular analysis of human breast cancer.
Fuller AP; Palmer-Toy D; Erlander MG; Sgroi DC
J Mammary Gland Biol Neoplasia; 2003 Jul; 8(3):335-45. PubMed ID: 14973377
[TBL] [Abstract][Full Text] [Related]
4. Protein pathway activation mapping of brain metastasis from lung and breast cancers reveals organ type specific drug target activation.
Improta G; Zupa A; Fillmore H; Deng J; Aieta M; Musto P; Liotta LA; Broaddus W; Petricoin EF; Wulfkuhle JD
J Proteome Res; 2011 Jul; 10(7):3089-97. PubMed ID: 21574647
[TBL] [Abstract][Full Text] [Related]
5. Application of laser microdissection and reverse-phase protein microarrays to the molecular profiling of cancer signal pathway networks in the tissue microenvironment.
Espina V; Wulfkuhle J; Liotta LA
Clin Lab Med; 2009 Mar; 29(1):1-13. PubMed ID: 19389547
[TBL] [Abstract][Full Text] [Related]
6. Combining laser capture microdissection and proteomics: methodologies and clinical applications.
Xu BJ
Proteomics Clin Appl; 2010 Feb; 4(2):116-23. PubMed ID: 21137037
[TBL] [Abstract][Full Text] [Related]
7. In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology.
Cha S; Imielinski MB; Rejtar T; Richardson EA; Thakur D; Sgroi DC; Karger BL
Mol Cell Proteomics; 2010 Nov; 9(11):2529-44. PubMed ID: 20739354
[TBL] [Abstract][Full Text] [Related]
8. Combining laser capture microdissection and proteomics techniques.
Mustafa D; Kros JM; Luider T
Methods Mol Biol; 2008; 428():159-78. PubMed ID: 18287773
[TBL] [Abstract][Full Text] [Related]
9. Analysis of laser capture microdissected cells by 2-dimensional gel electrophoresis.
Zhang D; Koay ES
Methods Mol Biol; 2008; 428():77-91. PubMed ID: 18287769
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis in human breast cancer: identification of a characteristic protein expression profile of malignant breast epithelium.
Hudelist G; Singer CF; Pischinger KI; Kaserer K; Manavi M; Kubista E; Czerwenka KF
Proteomics; 2006 Mar; 6(6):1989-2002. PubMed ID: 16470630
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer proteomics by laser capture microdissection, sample pooling, 54-cm IPG IEF, and differential iodine radioisotope detection.
Neubauer H; Clare SE; Kurek R; Fehm T; Wallwiener D; Sotlar K; Nordheim A; Wozny W; Schwall GP; Poznanović S; Sastri C; Hunzinger C; Stegmann W; Schrattenholz A; Cahill MA
Electrophoresis; 2006 May; 27(9):1840-52. PubMed ID: 16645950
[TBL] [Abstract][Full Text] [Related]
12. The advantage of laser-capture microdissection over whole tissue analysis in proteomic profiling studies.
De Marchi T; Braakman RB; Stingl C; van Duijn MM; Smid M; Foekens JA; Luider TM; Martens JW; Umar A
Proteomics; 2016 May; 16(10):1474-85. PubMed ID: 27030549
[TBL] [Abstract][Full Text] [Related]
13. Laser capture microdissection applications in breast cancer proteomics.
Braakman RB; Luider TM; Martens JW; Foekens JA; Umar A
Methods Mol Biol; 2011; 755():143-54. PubMed ID: 21761300
[TBL] [Abstract][Full Text] [Related]
14. Combining the "Sibling Technologies" of Laser Capture Microdissection and Reverse Phase Protein Microarrays.
Mueller C; Davis JB; Liotta LA
Adv Exp Med Biol; 2019; 1188():95-111. PubMed ID: 31820385
[TBL] [Abstract][Full Text] [Related]
15. Automated laser capture microdissection for tissue proteomics.
Rodriguez AS; Espina BH; Espina V; Liotta LA
Methods Mol Biol; 2008; 441():71-90. PubMed ID: 18370312
[TBL] [Abstract][Full Text] [Related]
16. Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy.
Wulfkuhle JD; Speer R; Pierobon M; Laird J; Espina V; Deng J; Mammano E; Yang SX; Swain SM; Nitti D; Esserman LJ; Belluco C; Liotta LA; Petricoin EF
J Proteome Res; 2008 Apr; 7(4):1508-17. PubMed ID: 18257519
[TBL] [Abstract][Full Text] [Related]
17. Reverse phase protein arrays: mapping the path towards personalized medicine.
Gallagher RI; Espina V
Mol Diagn Ther; 2014 Dec; 18(6):619-30. PubMed ID: 25358623
[TBL] [Abstract][Full Text] [Related]
18. Reverse phase protein microarrays for theranostics and patient-tailored therapy.
Espina V; Wulfkuhle J; Calvert VS; Liotta LA; Petricoin EF
Methods Mol Biol; 2008; 441():113-28. PubMed ID: 18370315
[TBL] [Abstract][Full Text] [Related]
19. Proteomics of breast cancer: enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors.
Zhang DH; Tai LK; Wong LL; Sethi SK; Koay ES
Proteomics; 2005 May; 5(7):1797-805. PubMed ID: 15825149
[TBL] [Abstract][Full Text] [Related]
20. Proteomic patterns for cancer diagnosis--promise and challenges.
Whiteley GR
Mol Biosyst; 2006 Aug; 2(8):358-63. PubMed ID: 16880955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
